Testing for peripheral artery disease (PAD) has never held more significance in the realm of healthcare. Among older adults, diabetic individuals, and those who smoke, nearly one-third are at a heightened risk for developing PAD. The repercussions of PAD are indeed grave; it brings about a 2-to-6-fold increase in cardiovascular mortality, thereby posing a substantial threat to life itself. Furthermore, this ailment elevates the probability of amputation, disability, and a perceptible decline in the overall quality of life.
At the core of identifying PAD’s onset lies the Ankle Brachial Index (ABI) test, a pivotal diagnostic tool. This assessment quantifies blood flow to the legs and feet, unveiling any underlying irregularities indicative of PAD. The ABI test—also known as the ankle brachial index test—assumes a central role in early detection, offering a proactive approach to manage this condition.
Performing an ABI test is now more streamlined, thanks to our comprehensive range of user-friendly SimpleABI systems. These cutting-edge systems are adept at providing essential information and comprehensive reports promptly and with intuitive ease. Notably, every member of our vascular ABI family is meticulously crafted within the United States, attesting to our commitment to quality and precision. With a noteworthy industry-leading 2-year warranty, our machines exemplify reliability and long-term value.
Make an informed choice for the well-being of your patients. Embrace the efficiency and accuracy that SimpleABI brings to PAD testing, paving the way for early intervention and enhanced patient care. Your patients’ cardiovascular health deserves nothing less than the best.